Month: July 2014

Home » Archives for July 2014

Combination of Prostate Cancer and Depression Obstructs Healing

Although researchers don’t exactly understand the role depression plays in a person’s overall cancer survival, a new study looking at prostate cancer in men offers more light. A number of studies have shown that people diagnosed with breast and liver cancer, who also maintain a positive outlook on life, tend to have better overall survival rates than those who become depressed. Read the article.

Combination of Prostate Cancer and Depression Obstructs Healing Read More »

Doctors suggest widely varying treatments; second opinion vital

Many men may not be getting the best advice when it comes to managing low-risk prostate cancer, two new studies suggest. In the first study, researchers found that most men are getting their prostate removed or undergoing radiation therapy when carefully watching the cancer may be just as effective without the risks and side effects of surgery or radiation. Read the article.

Doctors suggest widely varying treatments; second opinion vital Read More »

Chemo-ADT Combo Ups Survival in Patients with Metastatic PCa

Starting chemotherapy along with androgen deprivation therapy (ADT) in patients newly diagnosed with metastatic prostate cancer (mPCa) improved median overall survival by more than 13 months, according to a study presented at the American Society of Clinical Oncology annual meeting in Chicago. Read the article.

Chemo-ADT Combo Ups Survival in Patients with Metastatic PCa Read More »

VIDEO: Dr. Andrew Loblaw, “Image-Guided Diagnosis and Treatment- The Future of Prostate Cancer has Arrived!”

  May 2014 Scotiabank Awareness Night “Image-Guided Diagnosis and Treatment- The Future of Prostate Cancer has Arrived!” Dr. Andrew Loblaw   MD, MSc, FRCSC Sunnybrook Health Sciences Centre Staff Radiation Oncologist, Odette Cancer Centre Associate Professor, Department of Radiation Oncology, University of Toronto Associate Professor, Department of Health Policy, Management and Evaluation, University of Toronto Courtesy Staff, Department of Surgery, North York General Hospital   Surgical Oncology, Division of Urology, University Health Network   Dr. Loblaw reviews the advantages of Magnetic Resonance Imaging (MRI) in the diagnosis and treatment of prostate cancer and the outcomes of image-guided radiation treatment for prostate cancer. He discusses the

VIDEO: Dr. Andrew Loblaw, “Image-Guided Diagnosis and Treatment- The Future of Prostate Cancer has Arrived!” Read More »

Omega-3s and Prostate Cancer: What to Advise Patients

[Ed. note: Here’s an article illustrating the pro and con of diet. The bottom line seems to be that heart-healthy is all-healthy.] On July 10, 2013, Theodore M. Brasky, PhD, of the Ohio State University Comprehensive Cancer Center in Columbus, and colleagues published a study in the Journal of the National Cancer Institute (2013;105:1132-1141) that they said confirms previous reports of increased prostate cancer (PCa) risk among men with high blood levels of long-chain omega-3 polyunsaturated fatty acids. Two months later, a team led by James J. DiNicolantonio, PharmD, of the Mid America Heart Institute at Saint Luke’s Hospital in

Omega-3s and Prostate Cancer: What to Advise Patients Read More »

Scroll to Top